Y
Yunes Panahi
Researcher at Baqiyatallah University of Medical Sciences
Publications - 278
Citations - 9051
Yunes Panahi is an academic researcher from Baqiyatallah University of Medical Sciences. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 40, co-authored 268 publications receiving 6658 citations. Previous affiliations of Yunes Panahi include Yahoo!.
Papers
More filters
Journal ArticleDOI
Changing treatment protocol from azathioprine to mycophenolate mofetil: decrease in renal dysfunction, increase in infections.
TL;DR: The shift in the immunosuppression protocol from AZA to MMF, albeit advantageous in many instances, can sometimes undermine the outcome by giving rise to such complications as high infection rates.
Journal Article
Factors affecting the duration of mechanical ventilation device isolation of patients in intensive care units
Journal ArticleDOI
Neuroprotective Agents in the Intensive Care Unit: -Neuroprotective Agents in ICU.
Yunes Panahi,Mojtaba Mojtahedzadeh,Atabak Najafi,Seyyed Mahdi Rajaee,Mohammad Torkaman,Amirhossein Sahebkar +5 more
TL;DR: This study reviews neuroprotective agents and their mechanisms of action against central nervous system damages and finds that inhibition of inflammatory processes and apoptosis, attenuation of oxidative stress and reduction of free radicals are effective neuroprotectants.
Journal Article
Ocular Effects of Sulfur Mustard
TL;DR: Mustard gas keratopathy (MGK) is a devastating late complication of SM intoxication that proceeds from limbal stem cell deficiency (LSCD) and leading to a broad spectrum of ocular manifestations in terms of severity, timing and form.
Journal ArticleDOI
A new potentiometric sensor based on a high-performance composite for nanomolar determination of mercury (II) in environmental samples
TL;DR: In this article, a new potentiometric sensor for the rapid determination of Hg2+ based on modified carbon paste electrode consisting of room temperature ionic liquid, 1-Butyl-3methylimidazolium hexafluorophosphate (BMIM-PF6), multi-walled carbon nanotubes (MWCNTs), alumina nanoparticles and a synthetic macrocyclic diamide ‘7,10,13-triaza-1-thia-4,16-dioxa-6, 14,dioxo